To achieve MHC Class II antigen presentation tumor cells were either transduced with CIITA the transcriptional activator of genes encoding the MHC Class II antigen presentation machinery (146, 197), or pretreated with IFNγ, known as potent inducer of MHC Class II expression (12). The gene discussed is CIITA; the disease is neoplasm.